StemCells (STEM) Is Today's Perilous Reversal Stock

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Trade-Ideas LLC identified StemCells ( STEM) as a "perilous reversal" (up big yesterday but down big today) candidate. In addition to specific proprietary factors, Trade-Ideas identified StemCells as such a stock due to the following factors:

  • STEM has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $17.7 million.
  • STEM has traded 2.2 million shares today.
  • STEM is down 3.3% today.
  • STEM was up 15.2% yesterday.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in STEM with the Ticky from Trade-Ideas. See the FREE profile for STEM NOW at Trade-Ideas

More details on STEM:

StemCells, Inc., a biopharmaceutical company, is engaged in the research, development, and commercialization of stem cell therapeutics, and related tools and technologies for stem cell-based research and drug discovery and development.

The average volume for StemCells has been 903,700 shares per day over the past 30 days. StemCells has a market cap of $86.6 million and is part of the health care sector and drugs industry. The stock has a beta of 1.96 and a short float of 3.8% with 0.23 days to cover.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.
null

If you liked this article you might like

These 5 Stocks Under $10 Could Make You a Lot of Money

These 5 Stocks Under $10 Could Make You a Lot of Money

StemCells (STEM) Stock Plummets, CEO, CFO Resign

StemCells (STEM) Stock Plummets, CEO, CFO Resign

One Reason Why StemCells (STEM) Stock Is Down Today

One Reason Why StemCells (STEM) Stock Is Down Today

Closing Bell: Crude Oil Rallies Into Day Four; U.S. Stocks Fall From Records

Closing Bell: Crude Oil Rallies Into Day Four; U.S. Stocks Fall From Records

StemCells (STEM) Stock Skyrockets on Microbot Medical Merger

StemCells (STEM) Stock Skyrockets on Microbot Medical Merger